|
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
|
12 Months Ended |
|
Dec. 31, 2013
|
| Summary Of Significant Accounting Policies Tables |
|
| Cash and cash equivalents |
Cash and cash equivalents as of December 31 are
composed of:
| |
|
2013 |
|
|
2012 |
|
| Cash |
|
$ |
1,903,000 |
|
|
$ |
1,444,000 |
|
| Money market fund |
|
|
17,035,000 |
|
|
|
20,539,000 |
|
| Total |
|
$ |
18,938,000 |
|
|
$ |
21,983,000 |
|
|
| Computations of basic and diluted weighted average common shares outstanding |
Computations of basic and diluted weighted
average common shares outstanding are as follows:
| |
|
2013 |
|
|
2012 |
|
| |
|
|
|
|
|
|
| Weighted-average common shares outstanding - basic |
|
|
25,589,238 |
|
|
|
25,744,330 |
|
| |
|
|
|
|
|
|
|
|
| Dilutive effect of options and warrants |
|
|
2,365,447 |
|
|
_2,728,423 |
|
| |
|
|
|
|
|
|
|
|
| Weighted-average common shares outstanding - diluted |
|
|
27,954,685 |
|
|
|
28,472,753 |
|
| |
|
|
|
|
|
|
|
|
| Options and Warrants excluded from the computation of diluted income (loss) per share because the effect of inclusion would have been anti-dilutive |
|
|
4,417,053 |
|
|
|
3,104,077 |
|
|
| Financial assets subject to fair value measurements |
The Company’s financial assets subject to fair value measurements
and the necessary disclosures are as follows:
| |
|
Fair Value as
of December
|
|
|
Fair Value Measurements at December 31,
2013 Using Fair Value Hierarchy
|
|
| |
|
31, 2013
|
|
|
Level 1 |
|
|
Level 2 |
|
|
Level 3 |
|
| Cash and cash equivalents |
|
$ |
18,938,000 |
|
|
$ |
18,938,000 |
|
|
$ |
— |
|
|
$ |
— |
|
| Corporate bond |
|
|
530,000 |
|
|
|
— |
|
|
|
530,000 |
|
|
|
|
|
| Total |
|
$ |
19,468,000 |
|
|
$ |
18,938,000 |
|
|
$ |
530,000 |
|
|
$ |
— |
|
| |
|
Fair Value as
of December
|
|
|
Fair Value Measurements at December 31,
2012 Using Fair Value Hierarchy
|
|
| |
|
|
31, 2012 |
|
|
Level 1 |
|
|
Level 2 |
|
|
Level 3 |
|
| Cash and cash equivalents |
|
$ |
21,983,000 |
|
|
$ |
21,983,000 |
|
|
$ |
— |
|
|
$ |
— |
|
| Corporate bond |
|
|
547,000 |
|
|
|
— |
|
|
|
547,000 |
|
|
|
|
|
| Total |
|
$ |
22,530,000 |
|
|
$ |
21,983,000 |
|
|
$ |
547,000 |
|
|
$ |
— |
|
|
| Investment In Lifestreams |
At December 31, 2013, the Company’s Investment In Lifestreams
consists of the following:
| |
|
Number of
Shares
|
|
|
Value |
|
| Common Stock |
|
|
250,000 |
|
|
$ |
76,000 |
|
| Series A Preferred Stock |
|
|
123,456 |
|
|
|
50,000 |
|
| Warrants |
|
|
1,305,000 |
|
|
|
70,000 |
|
| |
|
|
|
|
|
$ |
196,000 |
|
|